bencyclane 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
301 2179-37-5

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • bencyclane
  • benzcyclan
  • benzcyclane
  • bencyclane fumarate
A vasodilator agent found to be effective in a variety of peripheral circulation disorders. It has various other potentially useful pharmacological effects. Its mechanism may involve block of calcium channels.
  • Molecular weight: 289.46
  • Formula: C19H31NO
  • CLOGP: 5.18
  • LIPINSKI: 1
  • HAC: 2
  • HDO: 0
  • TPSA: 12.47
  • ALOGS: -5.90
  • ROTB: 7

Drug dosage:

None

ADMET properties:

PropertyValueReference
BA (Bioavailability) 51 % Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H

Predicted pharmacokinetic/toxicological properties (PK-AZ):

PropertyDescriptionValueUnitConfidenceSimilarity
kinase-safety-class ACVR2A,ACVR2B,AKT1,AKT2,AKT3,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK4,CDK5,CDK9,DDR1,EIF2AK3,EPHB4,ERBB2,FLT3,GRK2,ITK,JAK2,JAK3,MAP3K7,MAPK10,MAPK12,MAPK7,MAPKAPK2,MET,MTOR,NTRK2,PDK2,PDK4,PDPK1,PIK3CB,PIM2,PRKDC,SIK2,SIK3,STK33,TEK,TGFBR1 41
kinase-selectivity-class AXL,CDK4,EIF2AK3,PDK4,TTK 5
pfas-class PFAS structural alert (1 = True, 0 = False) 0

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC C04AX11 CARDIOVASCULAR SYSTEM
PERIPHERAL VASODILATORS
PERIPHERAL VASODILATORS
Other peripheral vasodilators
MeSH PA D000077264 Calcium-Regulating Hormones and Agents
MeSH PA D002121 Calcium Channel Blockers
MeSH PA D002317 Cardiovascular Agents
MeSH PA D014665 Vasodilator Agents
MeSH PA D049990 Membrane Transport Modulators
CHEBI has role CHEBI:35554 cardiovascular drug

Related Drugs by ATC class:

C04AX Other peripheral vasodilators 16 drugs
azapetinebuflomedilbutalaminecetiedilcinepazideclazosentancyclandelatefasudilifenprodilmoxisylytenaftidrofurylphenoxybenzamine show all 16 →

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Cerebrovascular disease indication 62914000 DOID:6713




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 9.39 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
N0000166387 NUI
D07500 KEGG_DRUG
1367 RXNORM
C0004969 UMLSCUI
CHEBI:135205 CHEBI
CHEMBL2110767 ChEMBL_ID
DB13488 DRUGBANK_ID
D001537 MESH_DESCRIPTOR_UI
2312 PUBCHEM_CID
2111 INN_ID
6I97Z6S135 UNII
CHEMBL2105930 ChEMBL_ID
14286-84-1 SECONDARY_CAS_RN
007134 NDDF
007135 NDDF

Pharmaceutical products:

None